BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1687233)

  • 1. [Dependence on anticholinergics among schizophrenics. Iatrogenic disease or self-medication?].
    Chamorro García L
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1991; 19(6):298-303. PubMed ID: 1687233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
    Potvin S; Stip E; Roy JY
    Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abuse potential of anticholinergics.
    Dose M; Tempel HD
    Pharmacopsychiatry; 2000 Sep; 33 Suppl 1():43-6. PubMed ID: 11072764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No difference in the effect of biperiden and amantadine on negative symptoms in medicated chronic schizophrenic patients.
    Silver H; Geraisy N
    Biol Psychiatry; 1995 Sep; 38(6):413-5. PubMed ID: 8547463
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug abuse experience and neuroleptic prescriptions at the onset of schizophrenia].
    Lisoprawski A
    Sem Hop; 1983 Jun; 59(25):1925-7. PubMed ID: 6136096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biperiden and haloperidol plasma levels and extrapyramidal side effects in schizophrenic patients.
    Meszaros K; Lenzinger E; Hornik K; Schönbeck G; Hatzinger R; Langer G; Sieghart W; Aschauer HN
    Neuropsychobiology; 1997; 36(2):69-72. PubMed ID: 9267855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of anticholinergics on positive and negative symptoms in schizophrenia.
    Tandon R; DeQuardo JR; Goodson J; Mann NA; Greden JF
    Psychopharmacol Bull; 1992; 28(3):297-302. PubMed ID: 1480733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mood elevating effect of trihexyphenidyl and biperiden in individuals taking antipsychotic medication.
    Jellinek T
    Dis Nerv Syst; 1977 May; 38(5):353-5. PubMed ID: 852367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insomnia related to biperiden withdrawal in two schizophrenic patients.
    Hirose S
    Int Clin Psychopharmacol; 2000 Nov; 15(6):357-9. PubMed ID: 11110012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrapyramidal symptoms associated with alcohol withdrawal.
    Shen WW
    Biol Psychiatry; 1984 Jul; 19(7):1037-43. PubMed ID: 6477989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcohol, cannabis, nicotine, and caffeine use and symptom distress in schizophrenia.
    Hamera E; Schneider JK; Deviney S
    J Nerv Ment Dis; 1995 Sep; 183(9):559-65. PubMed ID: 7561817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug use and dependence in schizophrenia].
    Arias Horcajadas F; Padín Calo JJ; Fernández González MA
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1997; 25(6):379-89. PubMed ID: 9477606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biperiden (Akineton): effective prophylactic and therapeutic anti-parkinsonian agent.
    Kline NS; Mason BT; Winick L
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):838-43. PubMed ID: 4155670
    [No Abstract]   [Full Text] [Related]  

  • 14. Side-effects of antipsychotic medication and health-related quality of life in schizophrenia.
    Bebbington PE; Angermeyer M; Azorin JM; Marwaha S; Marteau F; Toumi M
    Acta Psychiatr Scand Suppl; 2009; (438):22-8. PubMed ID: 19132963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biperiden withdrawal in schizophrenic inpatients receiving long-term antipsychotic medication.
    Wada Y; Koshino Y; Yamaguchi N
    Clin Neuropharmacol; 1987 Aug; 10(4):370-5. PubMed ID: 2902920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biperiden abuse as a partial factor in polytoxicomania].
    Schulte RM
    Psychiatr Prax; 1988 Mar; 15(2):53-6. PubMed ID: 3387498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance abuse in clozapine-treated schizophrenic patients.
    Sand PG; Soyka M
    J Neuropsychiatry Clin Neurosci; 1997; 9(4):626-7. PubMed ID: 9447510
    [No Abstract]   [Full Text] [Related]  

  • 18. Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation.
    Schultz SK; Miller DD; Arndt S; Ziebell S; Gupta S; Andreasen NC
    Biol Psychiatry; 1995 Dec; 38(11):713-9. PubMed ID: 8580223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of neuroleptic dosage and extrapyramidal side effects on schizophrenic basic symptoms.
    Moritz S; Krausz M; Gottwalz E; Andresen B
    Compr Psychiatry; 2000; 41(4):284-8. PubMed ID: 10929797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of antipsychotic replacement with quetiapine on the symptoms and quality of life of schizophrenic patients with extrapyramidal symptoms.
    Taniguchi T; Sumitani S; Aono M; Iga J; Kinouchi S; Aki H; Matsushita M; Taniguchi K; Tsuno M; Yamanishi K; Tomotake M; Kaneda Y; Ohmori T
    Hum Psychopharmacol; 2006 Oct; 21(7):439-45. PubMed ID: 17029303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.